A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Published:2016-09-20 Issue:23 Volume:122 Page:3641-3649
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jimeno Antonio¹,Posner Marshall R.²,Wirth Lori J.³,Saba Nabil F.⁴,Cohen Roger B.⁵,Popa Elizabeta C.⁶,Argiris Athanassios⁷,Grossmann Kenneth F.⁸,Sukari Ammar⁹,Wilson Dawn¹⁰,Zhang Xiaosha¹⁰,Sun Jade¹⁰,Glasser Chad¹⁰,Attie Kenneth M.¹⁰,Sherman Matthew L.¹⁰,Pandya Susan S.¹⁰,Weiss Jared¹¹

Affiliation:

1. Departments of Medicine and Otolaryngology; University of Colorado Cancer Center and Gates Center for Regenerative Medicine; Aurora Colorado

2. Departments of Medicine and Otolaryngology; Icahn School of Medicine at Mount Sinai; New York New York

3. Department of Medicine; Massachusetts General Hospital; Boston Massachusetts

4. Department of Hematology and Medical Oncology; Emory University Winship Cancer Institute; Atlanta Georgia

5. Department of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

6. Department of Medicine; Joan and Sanford I Weill Cornell Medical College of Cornell University; New York New York

7. Department of Medicine, Institute of Drug Development; University of Texas Health Science Center at San Antonio; San Antonio Texas

8. Department of Internal Medicine; Huntsman Cancer Institute; Salt Lake City Utah

9. Karmanos Cancer Center; Wayne State University; Detroit Michigan

10. Acceleron Pharma; Cambridge Massachusetts

11. Department of Hematology and Oncology; University of North Carolina; Chapel Hill North Carolina

Funder

Acceleron Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Cancer Statistics, 2005;Jemal;CA Cancer J Clin,2005

3. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression;Chung;Cancer Cell,2004

4. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?;Sturgis;J Natl Compr Canc Netw,2011

5. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies;Vermorken;Cancer,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21

2. Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality;Anticancer Research;2023-11-29

3. Targeting Cytokines and Their Pathways for the Treatment of Cancer;Cancers;2023-10-30

4. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma;Journal of Inflammation Research;2023-09

5. A systematic literature review of the HPV prevalence in locally-regionally advanced (LA) and recurrent/metastatic (RM) head and neck cancers through the last decade: The ‘ALARM’ study;2023-03-09